R&D company with unique environmental purification technology
Mid-Long term Vision
634 fish farms operating nationwide on land.
Antibiotics administered to prevent the disease
Difficult to treat fish disease under the regulation of the authorities.
Aquarium-operated restaurants have trouble removing moss in the aquarium.
Complete development of green algae, red algae remover and moss remover in the first half of 2020
Target: Local governments, aquaculture companies, famous sushi and Japanese restaurants, and ornamental fish tank manufacturers
Baby Products Disinfectants
Market Status: A new market that does not exist in Korea yet
Partnership Chinese Company (more than 200 infant-related goods stores in China) entering the Chinese market
Patent application and independent brand launch
Disinfection & Protective Equipment
Develop our own brand product through technology alliance with professional defense equipment company
Providing manufacturers of defense equipment by developing defense cartridges
Medical Device/Dental Waterline / Hospital Sanitary Equipment
Most of the domestic dental waterline market is ozone sterilized.
Technical partnership with existing dental medical device distributors and development of chlorine dioxide waterline system (to be completed in the second half of 2020)
Separate business of medical devices and hospital disinfectants after disinfectant product approval (2nd half of 2020)
Funeral Supplies-corpse Cleaning Solvents, Shroud Disinfection
Chlorine dioxide is an eco-friendly disinfectant that does not generate harmful substances as a substitute for existing formalin-based disinfectants: corpse disinfection
Construction of sales network for national funeral associations and funeral homes in progress: scheduled for completion in the first half of 2002
Expected full-scale operation after disinfectant product approval (2H20)
Development of pharmaceuticals such as antibacterial ointment through technology cooperation with pharmaceutical companies
Technical cooperation with 5 pharmaceutical companies and development of basic formulation
OEM or ODM production through partnership with existing pharmaceutical companies